Background: Female sexual dysfunction are disorders of sexual desire, arousal, orgasm and sexual pain which lead to significant personal distress. Female sexual dysfunctions though common are often underreported. Aim:The aim of this study was to describe the prevalence and clinical correlates of sexual dysfunction among female diabetes mellitus patients attending the National Health Insurance Scheme Clinic of a tertiary hospital in Uyo SouthSouth Nigeria. Method:In a crosssectional study, 162 female diabetic patients were assessed for the prevalence of sexual dysfunction as well as affected domains of sexual function between January and June 2018. They were assessed using the female sexual function index (FSFI) questionnaire.Results: A total of 108 (66.7%) respondents had sexual dysfunction. The mean age at onset of diabetes mellitus among respondents with sexual dysfunction in this study was 43.6+6.1 compared to 39.3+4.3 among those without sexual dysfunction (p=0.04). Fortytwo (77.8%) respondents with sexual dysfunction had neuropathy involving the extremities compared to 12 (22.2%) without sexual dysfunction (p=0.050).Twenty-five (73.5%) respondents with sexual dysfunction were morbidly obese compared to nine (26.5%) without sexual dysfunction (p=0.018).The total FSFI score among respondents in this study was 22.6. Sexual pain was the most frequently experienced sexual dysfunction among respondents accounting for 93.5% (95% cl 93.499.3), the least affected domain of sexual function among respondents in this study was sexual desire accounting for 72.2% (95% cl 71.4 -85.0) Conclusion: Diabetes mellitus was associated with sexual dysfunction among respondents in this study. Primary care providers are encouraged to explore the presence of sexual dysfunction among female diabetic patients so as to offer adequate treatment and counselling as may be required. personal distress [2]. Good sexual and reproductive health and wellbeing are essential if people are to have responsible, safe and
Background: Blood transfusion is an invaluable therapeutic intervention in sickle cell anemia (SCA) patients’ care. Sickle cell anemia patients usually require frequent blood transfusion and are at increased risk of contracting human immunodeficiency virus (HIV), hepatitis B and C virus infections through these transfusions. Aims: To determine the seroprevalence of HIV, hepatitis B and C virus infections in patients’ with sickle cell anemia and the role of blood transfusion in the transmission of the infections. Methods: This was a prospective, observational cross-sectional study conducted on adult patients with SCA attending the Haematology Outpatient Clinic of University of Uyo Teaching Hospital, Uyo, from January 1, 2019 through December 31, 2019. Relevant clinical history was obtained from consenting subjects. Blood samples were collected for hemoglobin electrophoresis and viral antigen/antibody screening using ELISA kits. Data were analyzed using Statistical Package for Social Sciences (SPSS) windows version 23.0. Results: Eight-six patients with SCA participated in the study. Forty (46.5%) of the subjects were male and 63 (73.3%) of the participants were within the age range of 20–29 years. Seventy-five (87.2%) of the subjects had blood transfusion while 11 (12.8%) never received blood transfusion in their entire life. Seroprevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among the transfused SCA patients in this study was 9.3%, 24.0%, and 18.7% respectively while those not transfused had seroprevalence of 9.1% for HIV and 0% for both HBV and HCV. One (1.2%) of the transfused subjects tested positive for HIV and HCV. There was no statistically significant difference in the seroprevalence of HIV, HBV, and HCV infections in relation to the transfusion status of the subjects (p=0.98, 0.07, and 0.12, respectively). Conclusion: The proportion of our SCA patients who were HIV, HBV, and HCV positive was considerable. Blood transfusion did not significantly influence the seroprevalence rates of these viral infections. Measures aimed at controlling the infections in the patients and the general population should be scaled up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.